The activation mutation of NF-κB, Notch, JAK/ STAT3, RHOA and PI3K/AKT signaling pathways play an important role in the pathogenesis of PTCL [29, 75]. This evidence concerns the gene AKT1 and mature T-cell and NK-cell non-Hodgkin lymphoma.